Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Femtosecond Lasers: Expanding The Premium Cataract Surgery Market

Laser Cataract User Survey Shows Strong Initial Uptake

Executive Summary

When femtosecond lasers for cataract surgery hit the market in early 2011, it was apparent that that they would bring unprecedented precision to the procedure. The key questions surrounding this emerging field quickly shifted to commercial viability: how would US cataract surgeons and facilities be able to pay for this expensive new technology in a procedure that is reimbursed almost entirely by Medicare, and therefore subject to strict billing limitations? A survey of early laser adopters in the US, detailed below, suggests that surgeons are successfully navigating these regulatory hurdles and incorporating the new lasers into their practices.


Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts